Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study

Shikha Garg, Kadam Patel, Huong Pham, Michael Whitaker, Alissa O'Halloran, Jennifer Milucky, Onika Anglin, Pam D Kirley, Arthur Reingold, Breanna Kawasaki, Rachel Herlihy, Kimberly Yousey-Hindes, Amber Maslar, Evan J Anderson, Kyle P Openo, Andrew Weigel, Kenzie Teno, Patricia A Ryan, Maya L Monroe, Libby Reeg, Sue Kim, Kathryn Como-Sabetti, Erica Bye, Sarah Shrum Davis, Nancy Eisenberg, Alison Muse, Grant Barney, Nancy M Bennett, Christina B Felsen, Laurie Billing, Jess Shiltz, Melissa Sutton, Nasreen Abdullah, H Keipp Talbot, William Schaffner, Mary Hill, Ryan Chatelain, Jonathan Wortham, Christopher Taylor, Aron Hall, Alicia M Fry, Lindsay Kim, Fiona P Havers, Shikha Garg, Kadam Patel, Huong Pham, Michael Whitaker, Alissa O'Halloran, Jennifer Milucky, Onika Anglin, Pam D Kirley, Arthur Reingold, Breanna Kawasaki, Rachel Herlihy, Kimberly Yousey-Hindes, Amber Maslar, Evan J Anderson, Kyle P Openo, Andrew Weigel, Kenzie Teno, Patricia A Ryan, Maya L Monroe, Libby Reeg, Sue Kim, Kathryn Como-Sabetti, Erica Bye, Sarah Shrum Davis, Nancy Eisenberg, Alison Muse, Grant Barney, Nancy M Bennett, Christina B Felsen, Laurie Billing, Jess Shiltz, Melissa Sutton, Nasreen Abdullah, H Keipp Talbot, William Schaffner, Mary Hill, Ryan Chatelain, Jonathan Wortham, Christopher Taylor, Aron Hall, Alicia M Fry, Lindsay Kim, Fiona P Havers

Abstract

Background: The COVID-19 pandemic has caused substantial morbidity and mortality.

Objective: To describe monthly clinical trends among adults hospitalized with COVID-19.

Design: Pooled cross-sectional study.

Setting: 99 counties in 14 states participating in the Coronavirus Disease 2019-Associated Hospitalization Surveillance Network (COVID-NET).

Patients: U.S. adults (aged ≥18 years) hospitalized with laboratory-confirmed COVID-19 during 1 March to 31 December 2020.

Measurements: Monthly hospitalizations, intensive care unit (ICU) admissions, and in-hospital death rates per 100 000 persons in the population; monthly trends in weighted percentages of interventions, including ICU admission, mechanical ventilation, and vasopressor use, among an age- and site-stratified random sample of hospitalized case patients.

Results: Among 116 743 hospitalized adults with COVID-19, the median age was 62 years, 50.7% were male, and 40.8% were non-Hispanic White. Monthly rates of hospitalization (105.3 per 100 000 persons), ICU admission (20.2 per 100 000 persons), and death (11.7 per 100 000 persons) peaked during December 2020. Rates of all 3 outcomes were highest among adults aged 65 years or older, males, and Hispanic or non-Hispanic Black persons. Among 18 508 sampled hospitalized adults, use of remdesivir and systemic corticosteroids increased from 1.7% and 18.9%, respectively, in March to 53.8% and 74.2%, respectively, in December. Frequency of ICU admission, mechanical ventilation, and vasopressor use decreased from March (37.8%, 27.8%, and 22.7%, respectively) to December (20.5%, 12.3%, and 12.8%, respectively); use of noninvasive respiratory support increased from March to December.

Limitation: COVID-NET covers approximately 10% of the U.S. population; findings may not be generalizable to the entire country.

Conclusion: Rates of COVID-19-associated hospitalization, ICU admission, and death were highest in December 2020, corresponding with the third peak of the U.S. pandemic. The frequency of intensive interventions for management of hospitalized patients decreased over time. These data provide a longitudinal assessment of clinical trends among adults hospitalized with COVID-19 before widespread implementation of COVID-19 vaccines.

Primary funding source: Centers for Disease Control and Prevention.

Conflict of interest statement

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M21-1991.

Figures

Visual Abstract.. Clinical Trends in COVID-19 Hospitalizations.
Visual Abstract.. Clinical Trends in COVID-19 Hospitalizations.
This study used data from a national CDC network to examine trends related to COVID-19 hospitalization, care, and clinical outcomes across the United States.
Figure 1.. Rates (with 95% CIs) of…
Figure 1.. Rates (with 95% CIs) of COVID-19–associated hospitalization, ICU admission, and in-hospital death, by age group and month.
For hospitalization rate calculations, all identified cases in the Coronavirus Disease 2019–Associated Hospitalization Surveillance Network were used (n = 116 743). Unadjusted hospitalization rates per 100 000 persons in the population were calculated by taking the total number of hospitalized case patients each month, divided by 2019 bridged-race postcensal estimates of the population from the National Center for Health Statistics (NCHS), for the counties included in surveillance. For calculation of ICU admission and in-hospital death rates, a sample of hospitalized case patients with completed medical record review and a discharge disposition was used (n = 18 508). Unadjusted ICU admission and in-hospital death rates per 100 000 persons in the population among hospitalized patients were calculated using the weighted number of sampled case patients per month with each outcome as the numerator, divided by 2019 bridged-race postcensal estimates of the population from the National Center for Health Statistics (NCHS), for the counties included in surveillance. ICU = intensive care unit.
Appendix Figure.. Rates (with 95% CIs) of…
Appendix Figure.. Rates (with 95% CIs) of COVID-19–associated hospitalization, ICU admission, and in-hospital death, by age and race/ethnicity.
Y-axis scales vary across panels. “Hispanic” indicates Hispanic or Latino. ICU = intensive care unit. * All hospitalized Coronavirus Disease 2019–Associated Hospitalization Surveillance Network (COVID-NET) case patients with known race/ethnicity who were classified as non-Hispanic White, non-Hispanic Black, or Hispanic were included in this analysis (n = 101 021). Unadjusted hospitalization rates per 100 000 persons in the population were calculated by taking the total number of hospitalized case patients each month, divided by 2019 bridged-race postcensal estimates of the population from the National Center for Health Statistics (NCHS), for the counties included in surveillance. † A sample of hospitalized COVID-NET case patients with completed medical record review, a discharge disposition, and known race/ethnicity who were classified as non-Hispanic White, non-Hispanic Black, or Hispanic was used in this analysis (n = 16 035). Unadjusted rates of ICU admission and in-hospital death per 100 000 persons in the population among hospitalized patients were calculated using the weighted number of sampled cases per month with each outcome as the numerator, divided by 2019 bridged-race postcensal estimates of the population from the National Center for Health Statistics (NCHS), for the counties included in surveillance.
Figure 2.. Trends in median length of…
Figure 2.. Trends in median length of stay and percentages of interventions and outcomes among a sample of hospitalized adults with COVID-19, by age group and month.
All percentages are weighted. ICU = intensive care unit.
Figure 3.. Trends in highest level of…
Figure 3.. Trends in highest level of respiratory support received among a sample of hospitalized adults with COVID-19, by age group and month.
All percentages are weighted. BIPAP = bilevel positive airway pressure; CPAP = continuous positive airway pressure; ICU = intensive care unit.

References

    1. Reese H , Iuliano AD , Patel NN , et al. Estimated incidence of coronavirus disease 2019 (COVID-19) illness and hospitalization—United States, February–September 2020. Clin Infect Dis. 2021;72:e1010-e1017. [PMID: ] doi:10.1093/cid/ciaa1780
    1. Centers for Disease Control and Prevention. Estimated disease burden of COVID-19. 2020. Accessed at on 20 April 2021.
    1. Bhatraju PK , Ghassemieh BJ , Nichols M , et al. Covid-19 in critically ill patients in the Seattle region — case series. N Engl J Med. 2020;382:2012-2022. [PMID: ] doi:10.1056/NEJMoa2004500
    1. Cummings MJ , Baldwin MR , Abrams D , et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763-1770. [PMID: ] doi:10.1016/S0140-6736(20)31189-2
    1. Garg S , Kim L , Whitaker M , et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 — COVID-NET, 14 states, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458-464. [PMID: ] doi:10.15585/mmwr.mm6915e3
    1. Goyal P , Choi JJ , Pinheiro LC , et al. Clinical characteristics of Covid-19 in New York City [Letter]. N Engl J Med. 2020;382:2372-2374. [PMID: ] doi:10.1056/NEJMc2010419
    1. Kim L , Garg S , O'Halloran A , et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clin Infect Dis. 2021;72:e206-e214. [PMID: ] doi:10.1093/cid/ciaa1012
    1. Ko JY , Danielson ML , Town M , et al; COVID-NET Surveillance Team. Risk factors for coronavirus disease 2019 (COVID-19)–associated hospitalization: COVID-19–Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin Infect Dis. 2021;72:e695-e703. [PMID: ] doi:10.1093/cid/ciaa1419
    1. Petrilli CM , Jones SA , Yang J , et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. [PMID: ] doi:10.1136/bmj.m1966
    1. Richardson S , Hirsch JS , Narasimhan M , et al; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052-2059. [PMID: ] doi:10.1001/jama.2020.6775
    1. Anesi GL , Jablonski J , Harhay MO , et al. Characteristics, outcomes, and trends of patients with COVID-19-related critical illness at a learning health system in the United States. Ann Intern Med. 2021;174:613-621. [PMID: ] doi:10.7326/M20-5327
    1. Horwitz LI , Jones SA , Cerfolio RJ , et al. Trends in COVID-19 risk-adjusted mortality rates. J Hosp Med. 2021;16:90-92. [PMID: ] doi:10.12788/jhm.3552
    1. Armstrong RA , Kane AD , Cook TM . Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia. 2020;75:1340-1349. [PMID: ] doi:10.1111/anae.15201
    1. Asch DA , Sheils NE , Islam MN , et al. Variation in US hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic. JAMA Intern Med. 2021;181:471-478. [PMID: ] doi:10.1001/jamainternmed.2020.8193
    1. Auld SC , Caridi-Scheible M , Robichaux C , et al; Emory COVID-19 Quality and Clinical Research Collaborative. Declines in mortality over time for critically ill adults with coronavirus disease 2019 [Letter]. Crit Care Med. 2020;48:e1382-e1384. [PMID: ] doi:10.1097/CCM.0000000000004687
    1. Boehmer TK , DeVies J , Caruso E , et al. Changing age distribution of the COVID-19 pandemic — United States, May–August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1404-1409. [PMID: ] doi:10.15585/mmwr.mm6939e1
    1. Joo H , Miller GF , Sunshine G , et al. Decline in COVID-19 hospitalization growth rates associated with statewide mask mandates — 10 states, March–October 2020. MMWR Morb Mortal Wkly Rep. 2021;70:212-216. [PMID: ] doi:10.15585/mmwr.mm7006e2
    1. Gandhi M , Rutherford GW . Facial masking for Covid-19 — potential for “variolation” as we await a vaccine. N Engl J Med. 2020;383:e101. [PMID: ] doi:10.1056/NEJMp2026913
    1. Beigel JH , Tomashek KM , Dodd LE , et al; ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19 — final report. N Engl J Med. 2020;383:1813-1826. [PMID: ] doi:10.1056/NEJMoa2007764
    1. Horby P , Lim WS , Emberson JR , et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693-704. [PMID: ] doi:10.1056/NEJMoa2021436
    1. Kalil AC , Patterson TF , Mehta AK , et al; ACTT-2 Study Group Members. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med. 2021;384:795-807. [PMID: ] doi:10.1056/NEJMoa2031994
    1. Paranjpe I , Fuster V , Lala A , et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19 [Letter]. J Am Coll Cardiol. 2020;76:122-124. [PMID: ] doi:10.1016/j.jacc.2020.05.001
    1. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Updated 28 August 2020. Accessed at on 20 April 2021.
    1. Centers for Disease Control and Prevention. U.S. Census populations with bridged race categories. National Vital Statistics System. 2019. Accessed at on 20 April 2021.
    1. Finelli L , Gupta V , Petigara T , et al. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open. 2021;4:e216556. [PMID: ] doi:10.1001/jamanetworkopen.2021.6556
    1. Peckham H , de Gruijter NM , Raine C , et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020;11:6317. [PMID: ] doi:10.1038/s41467-020-19741-6
    1. Vahidy FS , Pan AP , Ahnstedt H , et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: cross-sectional analysis from a diverse US metropolitan area. PLoS One. 2021;16:e0245556. [PMID: ] doi:10.1371/journal.pone.0245556
    1. Escobar GJ , Adams AS , Liu VX , et al. Racial disparities in COVID-19 testing and outcomes. Retrospective cohort study in an integrated health system. Ann Intern Med. 2021;174:786-793. [PMID: ] doi:10.7326/M20-6979
    1. Gold JAW , Wong KK , Szablewski CM , et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 — Georgia, March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:545-550. [PMID: ] doi:10.15585/mmwr.mm6918e1
    1. Karaca-Mandic P , Georgiou A , Sen S . Assessment of COVID-19 hospitalizations by race/ethnicity in 12 states. JAMA Intern Med. 2021;181:131-134. [PMID: ] doi:10.1001/jamainternmed.2020.3857
    1. Mackey K , Ayers CK , Kondo KK , et al. Racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths. A systematic review. Ann Intern Med. 2021;174:362-373. [PMID: ] doi:10.7326/M20-6306
    1. Muñoz-Price LS , Nattinger AB , Rivera F , et al. Racial disparities in incidence and outcomes among patients with COVID-19. JAMA Netw Open. 2020;3:e2021892. [PMID: ] doi:10.1001/jamanetworkopen.2020.21892
    1. Price-Haywood EG , Burton J , Fort D , et al. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020;382:2534-2543. [PMID: ] doi:10.1056/NEJMsa2011686
    1. Centers for Disease Control and Prevention. Introduction to COVID-19 racial and ethnic health disparities. Updated 10 December 2020. Accessed at on 20 April 2021.
    1. Dai CL , Kornilov SA , Roper RT , et al. Characteristics and factors associated with COVID-19 infection, hospitalization, and mortality across race and ethnicity. Clin Infect Dis. 2021. [PMID: ] doi:10.1093/cid/ciab154
    1. Podewils LJ , Burket TL , Mettenbrink C , et al. Disproportionate incidence of COVID-19 infection, hospitalizations, and deaths among persons identifying as Hispanic or Latino — Denver, Colorado March–October 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1812-1816. [PMID: ] doi:10.15585/mmwr.mm6948a3
    1. Mathews KS , Soh H , Shaefi S , et al; STOP-COVID Investigators. Prone positioning and survival in mechanically ventilated patients with coronavirus disease 2019–related respiratory failure. Crit Care Med. 2021;49:1026-1037. [PMID: ] doi:10.1097/CCM.0000000000004938
    1. Mellado-Artigas R , Ferreyro BL , Angriman F , et al; COVID-19 Spanish ICU Network. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care. 2021;25:58. [PMID: ] doi:10.1186/s13054-021-03469-w
    1. Coppadoro A , Benini A , Fruscio R , et al. Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak. Crit Care. 2021;25:80. [PMID: ] doi:10.1186/s13054-021-03502-y
    1. National Institutes of Health. COVID-19 treatment guidelines: chloroquine or hydroxychloroquine with or without azithromycin. 2020. Accessed at on 20 April 2021.
    1. Kalil AC , Patterson TF , Mehta AK , et al; ACTT-2 Study Group Members. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med. 2021;384:795-807. [PMID: ] doi:10.1056/NEJMoa2031994
    1. Salama C , Han J , Yau L , et al. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J Med. 2021;384:20-30. [PMID: ] doi:10.1056/NEJMoa2030340
    1. Wu H , Soe MM , Konnor R , et al; National Healthcare Safety Network. Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27–July 14, 2020. Infect Control Hosp Epidemiol. 2021:1-4. [PMID: ] doi:10.1017/ice.2021.280
    1. Reddy YNV , Walensky RP , Mendu ML , et al. Estimating shortages in capacity to deliver continuous kidney replacement therapy during the COVID-19 pandemic in the United States. Am J Kidney Dis. 2020;76:696-709.e1. [PMID: ] doi:10.1053/j.ajkd.2020.07.005
    1. Bravata DM , Perkins AJ , Myers LJ , et al. Association of intensive care unit patient load and demand with mortality rates in US Department of Veterans Affairs hospitals during the COVID-19 pandemic. JAMA Netw Open. 2021;4:e2034266. [PMID: ] doi:10.1001/jamanetworkopen.2020.34266

Source: PubMed

3
Sottoscrivi